Predict your next investment

HEALTHCARE | Disease Diagnosis

See what CB Insights has to offer

Stage

Dead | Dead

Total Raised

$3.45M

About Pediatric Bioscience

Pediatric Bioscience (PBI) is a California-based specialty clinical diagnostic company dedicated to developing and commercializing novel products to improve the diagnosis and treatment of children with autism (AU) and autism spectrum disorders (ASD). PBI's products currently in development came from discoveries that were licensed from the UC Davis M.I.N.D. Institute, an international, multidisciplinary research organization. Pediatric Bioscience's first commercial test is a set of prognostic markers (The MAR Test) that identifies women who may be at an increased risk of having a child with autism.

Pediatric Bioscience Headquarter Location

10581 Roselle Street Suite 115

San Diego, California, 92121,

United States

858-320-2300

Latest Pediatric Bioscience News

Autism Spectrum Disorder Market Outlook 2021 – Technological Innovation | Major Players Actavis, Inc., Curemark LLC, Janssen Pharmaceuticals, Inc., Otsuka Holdings Co., Ltd., Pediatric BioScience, Inc., Teva Pharmaceutical Industries Ltd.

Sep 27, 2021

| Major Players Actavis, Inc., Curemark LLC, Janssen Pharmaceuticals, Inc., Otsuka Holdings Co., Ltd., Pediatric BioScience, Inc., Teva Pharmaceutical Industries Ltd. Autism Spectrum Disorder Market Overview: Autism is a developmental disorder affecting approximately 1 in 54 children in the U.S. (CDC 2016). Most individuals with autism spectrum disorder find social interactions difficult. The mutual give-and-take nature of typical communication and interaction is often particularly challenging. Some autism research points to the possibility of abnormal brain development due to abnormal gene expression in areas related to speech, language, memory, cognition, socialization, and response. This theory suggests that children with autism might be having brain development problems due to the abnormal communication patterns associated with autism. One theory suggests that abnormal brain development results in the absence of specific cells in the brain. It has also been suggested that the lack of these cells may be due to a lack of essential proteins that are needed for brain development. It is believed that the absence of these essential proteins results in impaired brain growth and function. Request for Sample Copy of Report with Analysis of COVID-19 Impact on Autism Spectrum Disorder Market – https://www.stratagemmarketinsights.com/sample/25196 Autism Spectrum Disorder Market Dynamics: Availability of various treatments is expected to propel the growth of the global autism spectrum disorder market over the forecast period. For instance, in June 2021, The Carolina Center for ABA and Autism Treatment announced to offer of Applied Behavioral Analysis treatment for children with Autism Spectrum Disorder in Winston-Salem, NC. Approval and launch of new diagnostic tools are expected to offer lucrative growth opportunities for players in the global autism spectrum disorder market. For instance, in June 2021, the U.S. Food and Drug Administration authorized the marketing of Cognoa ASD Diagnosis Aid, a machine learning-based software that helps to diagnose ASD. Autism Spectrum Disorder Market Key Takeaways: Availability of various treatments is expected to propel the growth of the global autism spectrum disorder market over the forecast period. For instance, in April 2021, Hopebridge Autism Therapy Centers, the autism service provider, added 6 new locations, bringing a total of 12 centers in Arizona. Major players in the global autism spectrum disorder market are focused on R&D to expand their product portfolio. For instance, in October 2020, Zynerba Pharmaceuticals, Inc. presented a poster describing data from the Phase 2 BRIGHT trial further demonstrating the potential for Zygel (ZYN002) to improve the core behavioral symptoms of autism when administered in addition to a stable standard of care in children and adolescents with moderate-to-severe ASD. Major players operating in the global autism spectrum disorder market include Actavis, Inc., Curemark LLC, Janssen Pharmaceuticals, Inc., Otsuka Holdings Co., Ltd., Pediatric BioScience, Inc., Teva Pharmaceutical Industries Ltd., Mylan Pharmaceuticals, Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb, Merck & Co., and Par Sterile Products, LLC. Autism Spectrum Disorder Market Segmentation: By Product Type, the market is primarily segmented into: Applied Behavior Analysis What does the report cover regarding the regional market landscape? The report, with respect to the geological spectrum of this scope, analyzes each geographic segment of the market with supply, import, export, consumption, and production in these regions to provide a complete understanding of the market, covering, (United States, Europe, China, Japan, Southeast Asia, India, Central & South America) Basic information with details on the Autism Spectrum Disorder market share held by the regions in the company of trade, business, for which all geographical explanations have been given in the report. Our commercial offers present fresh and reliable information useful to companies to strengthen their competitive advantage. Why Should Buy This Report From Stratagem Market Insights? This report offers a broad and concise analysis of the Autism Spectrum Disorder market using a robust research methodology and focusing on various data available for the historical period of the past few years. Provides in-depth research analysis of the overall Autism Spectrum Disorder market. which can help save time for start-up businesses related to the Autism Spectrum Disorder Market. The Autism Spectrum Disorder markets’ latest news, forecast analysis as well as the key competitors of the market are easily available with all the necessary information. This market report comprises graphs, pie charts, and other representations that can help the reader understand the information at a glance. Access an in-depth study with over 100 pages, a list of tables and figures, profiling of over 10 companies. Purchase this full business report: https://www.stratagemmarketinsights.com/cart/25196 About Us: Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. We strive to offer a sapient solution, expert consultations, and tailored/customized solutions. Our team includes analysts that leverage their years of experience and expertise to create accurate and error-free reports. The domain-specific teams are constantly focused on tracking markets, aiding our clients to gain a competitive edge through high-quality market intelligence. We offer an array of services including, syndicated research, advisory and consulting research process outsourcing, and content management. Contact Us:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.